Treatment of dementia: where is it going?
Global levels of dementia are escalating but alongside this new innovations and service models are developing to improve outcome and the patient journey. This article describes some of the current and horizon issues in dementia care.
Fox
Chris
C
Kent and Medway NHS, CHSS, University of Kent, Canterbury, Kent, UK.
Boustani
Malaz
M
Moniz-Cook
Esme
E
D002800:Cholinesterase Inhibitors / Q000627:therapeutic use*; D003704:Dementia / Q000175:diagnosis / Q000191:economics / Q000628:therapy*; D042241:Early Diagnosis; D006801:Humans; D016202:N-Methylaspartate / Q000037:antagonists & inhibitors*; D011613:Psychotherapy / Q000379:methods* / Q000639:trends; D011788:Quality of Life; D016896:Treatment Outcome
D002800:Cholinesterase Inhibitors; D016202:N-Methylaspartate